Resistentia Pharmaceuticals Ab

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

Forward Citations = 7

Loading Chart...

5 inventors (with patents filed for the assignee):

Lars T Hellman (3 out of 3 patents)

Ann-Christin Magnusson (1 out of 4 patents)

Mats Lundgren (1 out of 3 patents)

4. Rikard Holmdahl (1 out of 11 patents)

5. Alexis Fuentes (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7459158 - Immunogenic polypeptides for inducing anti-self IgE responses (2008-12-02),

2. 7361742 - Methods and materials for treating inflammatory conditions (2008-04-22),

3. 7232898 - Chimeric IgE polypeptides and host cells (2007-06-19),

4. 6913749 - Immunogenic polypeptides for inducing anti-self IgE responses (2005-07-05),

Company Overview

Resistentia Pharmaceuticals Ab is a biotechnology company focused on developing innovative therapies for the treatment of infectious diseases. The company specializes in creating novel antibiotic compounds to address the growing threat of antimicrobial resistance. Through cutting-edge research and strategic partnerships, Resistentia is dedicated to improving the lives of patients worldwide.Visit their website to learn more about their groundbreaking work in the field of infectious disease treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#65 in Uppsala

#1,305 in Sweden

Uppsala, Sweden